Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wiley Companies is a family-owned custom chemical and nutritional ingredient manufacturer that specializes in high-purity lipids and fine chemicals for the pharmaceutical, nutraceutical, and food industries. Based in Ohio, the company is globally recognized for its AlaskOmega® line of sustainable, MSC-certified omega-3 and omega-7 fish oil concentrates sourced from wild-caught Alaskan Pollock. Beyond its nutritional lipids portfolio, Wiley provides comprehensive contract development and manufacturing (CDMO) services, offering expertise in complex molecular distillation, organic synthesis, and high-purity chemical processing. The company operates multiple GMP-certified facilities and manages a diverse portfolio that includes the Wiley's Finest™ consumer brand, NovaPine™ plant sterols, and Cetyl Myristoleate products for joint health. With over 40 years of experience, Wiley Companies serves as a strategic partner for organizations requiring specialized ingredient solutions and advanced manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wiley Companies.